34% faster model refresh cycle for trial forecasting
A global biopharma platform team needed trial forecasting models to refresh faster without compromising the lineage regulators and internal audit expect. Radiantze replaced ad hoc notebook handoffs with a pipeline that moves curated features through training, validation, and promotion with clear ownership at each stage.
Radiantze aligned data engineering and clinical analytics sponsors on feature definitions, source systems of record, and refresh cadence tied to study milestones. Feature stores and transformation jobs were documented so scientists could trace any prediction back to originating trial data.
Automated tests guarded data quality gates before training jobs ran. Schema drift, missing cohorts, and out-of-range clinical measures blocked promotion until stewards resolved exceptions with recorded rationale.
Model validation included holdout sets representative of active trial portfolios, bias checks on key subgroups, and performance thresholds clinical leadership agreed in advance. Only passes triggered deployment artifacts consumable by downstream forecasting applications.
Cloud landing-zone patterns gave the pipeline elastic training capacity while FinOps tagging tied compute spend to therapeutic areas. Radiantze embedded MLOps runbooks so internal platform engineers could operate releases after hypercare.
Model refresh cycles for trial forecasting shortened by 34%, freeing data science capacity for new study questions instead of repetitive pipeline rebuilds. Radiantze continues enhancement sprints aligned to the team’s release calendar and audit calendar.
